New Challenges and Opportunities for Opioid Agonist Treatment Access and Retention: A Scoping Review
- 2 August 2024
- journal article
- research article
- Published by SAGE Publications in Journal of Drug Issues
- Vol. 56 (1) , 77-103
Abstract
Changes to the landscape of opioid use have occurred throughout the past two decades. Opioid agonist treatment (OAT) plays an important role in reducing opioid-related harms. Yet, people with opioid use disorder (PWOUD) face issues with access and retention. This scoping review sought to provide an up-to-date synthesis on barriers and facilitators to OAT. Ninety-three studies were included. Major barriers included cost, waiting lists, and negative public attitudes toward treatment. Prominent facilitators included OAT education and flexible treatment conditions such as telehealth-delivered OAT. In prison settings, limited support with treatment referral was a barrier. Fear of judgement was a challenge for pregnant people. There was a lack of information on barriers and facilitators specific to PWOUD dealing with chronic pain or mental health comorbidities. Results highlight new challenges in reaching an increasingly heterogeneous PWOUD population. Findings underline the potential for recent advancements in treatment modalities to promote access and retention.Keywords
Funding Information
- Ministère de la Santé et des Services sociaux
- Institut Universitaire sur les Dépendances
- Health Canada
This publication has 146 references indexed in Scilit:
- Trends in and Characteristics of Buprenorphine Misuse Among Adults in the USJAMA Network Open, 2021
- Factors Associated with Long-Term Retention in Buprenorphine-Based Addiction Treatment Programs: a Systematic ReviewJournal of General Internal Medicine, 2021
- Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid ReviewJournal of General Internal Medicine, 2020
- Barriers and facilitators systematic reviews in health: A methodological review and recommendations for reviewersResearch Synthesis Methods, 2020
- Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative StudyJournal of General Internal Medicine, 2020
- Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare BeneficiariesJAMA Network Open, 2020
- Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid DependenceJAMA, 2015
- The Changing Face of Heroin Use in the United StatesJAMA Psychiatry, 2014
- A Re-conceptualization of Access for 21st Century HealthcareJournal of General Internal Medicine, 2011
- The Quality of CareJAMA, 1988